Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia

The current global platelet supply is often insufficient to meet all the transfusion needs of patients, in particular for those with alloimmune thrombocytopenia. To address this issue, we have developed a strategy employing a combination of approaches to achieve more efficient production of function...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Bijender, Afshar-Kharghan, Vahid, Mendt, Mayela, Sackstein, Robert, Tanner, Mark R., Popat, Uday, Ramdial, Jeremy, Daher, May, Jimenez, Juan, Basar, Rafet, Melo Garcia, Luciana, Shanley, Mayra, Kaplan, Mecit, Wan, Xinhai, Nandivada, Vandana, Reyes Silva, Francia, Woods, Vernikka, Gilbert, April, Gonzalez-Delgado, Ricardo, Acharya, Sunil, Lin, Paul, Rafei, Hind, Banerjee, Pinaki Prosad, Shpall, Elizabeth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530569/
https://www.ncbi.nlm.nih.gov/pubmed/36203567
http://dx.doi.org/10.3389/fimmu.2022.1018047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530569/
https://www.ncbi.nlm.nih.gov/pubmed/36203567
http://dx.doi.org/10.3389/fimmu.2022.1018047

Ejemplares similares